Request Deal Involvement
D1 Capital Partners and Eventide Asset Management led a $100m Series B funding round in LEXEO Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Principals
bidder
D1 CAPITAL PARTNERS LP
bidder
ALEXANDRIA VENTURE INVESTMENTS
bidder
EVENTIDE ASSET MANAGEMENT
bidder
LONGITUDE CAPITAL MANAGEMENT CO LLC
bidder
OMEGA FUNDS
bidder
PBM CAPITAL GROUP
bidder
THE INVUS GROUP LLC
target
LEXEO THERAPEUTICS
bidder
CAM CAPITAL
bidder
VERITION FUND MANAGEMENT
bidder
LAURION CAPITAL MANAGEMENT
bidder
GRAY'S CREEK CAPITAL PARTNERS
bidder
LUNDBECKFONDEN VENTURES
bidder
JANUS HENDERSON INVESTORS
bidder
WOODLINE PARTNERS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite